This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Karel Decroos - Innovator in Pharmaceutical Science
Introduction
Karel Decroos is a prominent inventor located in Ghent, Belgium, recognized for his contributions to pharmaceutical science. His innovative research has led to the development of novel methods that are crucial in the preparation of essential pharmaceutical compounds.
Latest Patents
Decroos holds a patent titled "Solution phase method for preparing etelcalcetide." This patent outlines a solution phase fragment coupling method tailored for preparing etelcalcetide and its pharmaceutically acceptable salts. His work in this area highlights the importance of pharmaceutical innovation in enhancing treatment options.
Career Highlights
Currently, Karel Decroos is associated with Amgen Inc., a global biotechnology company known for its focus on developing innovative therapies. His work at Amgen has significantly contributed to the company's advancements in drug development, particularly in the area of peptide synthesis.
Collaborations
Throughout his career, Decroos has worked alongside notable colleagues, including Sheng Cui and Krishnakumar Ranganathan. These collaborations have played a vital role in advancing their collective research efforts and enhancing the impact of their findings within the pharmaceutical industry.
Conclusion
Karel Decroos stands out as an influential inventor whose work in pharmaceutical innovation reflects a commitment to improving healthcare outcomes. His pioneering methods for preparing essential compounds showcase the intersection of scientific research and practical applications in the medical field.